Search Results - "Mishra, Lopa"

Refine Results
  1. 1

    EMT, CTCs and CSCs in tumor relapse and drug-resistance by Mitra, Abhisek, Mishra, Lopa, Li, Shulin

    Published in Oncotarget (10-05-2015)
    “…Tumor relapse and metastasis are the primary causes of poor survival rates in patients with advanced cancer despite successful resection or chemotherapeutic…”
    Get full text
    Journal Article
  2. 2

    Technologies for deriving primary tumor cells for use in personalized cancer therapy by Mitra, Abhisek, Mishra, Lopa, Li, Shulin

    Published in Trends in biotechnology (Regular ed.) (01-06-2013)
    “…Highlights • Immortalized cancer cell lines cannot meet the needs of personalized medicine. • Primary cells from solid tumors are important in personalized…”
    Get full text
    Journal Article
  3. 3

    Cell‐surface Vimentin: A mislocalized protein for isolating csVimentin+CD133− novel stem‐like hepatocellular carcinoma cells expressing EMT markers by Mitra, Abhisek, Satelli, Arun, Xia, Xueqing, Cutrera, Jeffrey, Mishra, Lopa, Li, Shulin

    Published in International journal of cancer (15-07-2015)
    “…Recent advances in cancer stem cell biology have shown that cancer stem‐like cells with epithelial–mesenchymal transition (EMT) phenotypes are more aggressive…”
    Get full text
    Journal Article
  4. 4

    IL6‐mediated inflammatory loop reprograms normal to epithelial‐mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta–deficient β2‐spectrin+/− mice by Mitra, Abhisek, Yan, Jun, Xia, Xueqing, Zhou, Shouhao, Chen, Jian, Mishra, Lopa, Li, Shulin

    Published in Hepatology (Baltimore, Md.) (01-04-2017)
    “…Hepatocellular carcinoma (HCC) is the second‐leading cause of cancer‐related deaths worldwide with a poor survival rate. As many as 40% of HCCs are clonal,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications by Churi, Chaitanya R, Shroff, Rachna, Wang, Ying, Rashid, Asif, Kang, HyunSeon C, Weatherly, Jacqueline, Zuo, Mingxin, Zinner, Ralph, Hong, David, Meric-Bernstam, Funda, Janku, Filip, Crane, Christopher H, Mishra, Lopa, Vauthey, Jean-Nicholas, Wolff, Robert A, Mills, Gordon, Javle, Milind

    Published in PloS one (23-12-2014)
    “…Cholangiocarcinoma (CCA) is clinically heterogeneous; intra and extrahepatic CCA have diverse clinical presentations. Next generation sequencing (NGS)…”
    Get full text
    Journal Article
  7. 7
  8. 8

    IL‐30 (IL27p28) attenuates liver fibrosis through inducing NKG2D‐rae1 interaction between NKT and activated hepatic stellate cells in mice by Mitra, Abhisek, Satelli, Arun, Yan, Jun, Xueqing, Xia, Gagea, Mihai, Hunter, Christopher A., Mishra, Lopa, Li, Shulin

    Published in Hepatology (Baltimore, Md.) (01-12-2014)
    “…Chronic hepatic diseases, such as cirrhosis, hepatocellular carcinoma, and virus‐mediated immunopathogenic infections, affect billions of people worldwide…”
    Get full text
    Journal Article
  9. 9

    Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma by Wang, Han, Tsung, Allan, Mishra, Lopa, Huang, Hai

    Published in EBioMedicine (01-03-2024)
    “…Metabolic-dysfunction-associated steatotic liver disease (MASLD) is becoming a leading cause of end-stage liver disease globally…”
    Get full text
    Journal Article
  10. 10

    Cancer stem cells and hepatocellular carcinoma by Yao, Zhixing, Mishra, Lopa

    Published in Cancer biology & therapy (15-09-2009)
    “…Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide, with a median survival of 6 to 16 months. Factors responsible for the poor prognosis…”
    Get full text
    Journal Article
  11. 11

    Global and targeted serum metabolic profiling of colorectal cancer progression by Long, Yin, Sanchez‐Espiridion, Beatriz, Lin, Moubin, White, Lindsey, Mishra, Lopa, Raju, Gottumakkala S., Kopetz, Scott, Eng, Cathy, Hildebrandt, Michelle A. T., Chang, David W., Ye, Yuanqing, Liang, Dong, Wu, Xifeng

    Published in Cancer (15-10-2017)
    “…BACKGROUND Patients with colorectal adenoma polyps (PLPs) are at higher risk for developing colorectal cancer (CRC). However, the development of improved and…”
    Get full text
    Journal Article
  12. 12

    HER2/neu-directed therapy for biliary tract cancer by Javle, Milind, Churi, Chaitanya, Kang, HyunSeon C, Shroff, Rachna, Janku, Filip, Surapaneni, Rakesh, Zuo, Mingxin, Barrera, Christian, Alshamsi, Humaid, Krishnan, Sunil, Mishra, Lopa, Wolff, Robert A, Kaseb, Ahmed O, Thomas, Melanie B, Siegel, Abby B

    Published in Journal of hematology and oncology (29-05-2015)
    “…Biliary cancers are highly aggressive tumors that are often diagnosed an advanced disease stage and have a poor outcome with systemic therapy. Recent efforts…”
    Get full text
    Journal Article
  13. 13
  14. 14

    The somatic mutation landscape of premalignant colorectal adenoma by Lin, Shu-Hong, Raju, Gottumukkala S, Huff, Chad, Ye, Yuanqing, Gu, Jian, Chen, Jiun-Sheng, Hildebrandt, Michelle A T, Liang, Han, Menter, David G, Morris, Jeffery, Hawk, Ernest, Stroehlein, John R, Futreal, Andrew, Kopetz, Scott, Mishra, Lopa, Wu, Xifeng

    Published in Gut (01-07-2018)
    “…There are few studies which characterised the molecular alterations in premalignant colorectal adenomas. Our major goal was to establish colorectal adenoma…”
    Get more information
    Journal Article
  15. 15

    A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression by Wang, Rui-Hong, Li, Cuiling, Xu, Xiaoling, Zheng, Yin, Xiao, Cuiying, Zerfas, Patricia, Cooperman, Sharon, Eckhaus, Michael, Rouault, Tracey, Mishra, Lopa, Deng, Chu-Xia

    Published in Cell metabolism (01-12-2005)
    “…Hereditary hemochromatosis, characterized by iron overload in multiple organs, is one of the most common genetic disorders among Caucasians. Hepcidin, which is…”
    Get full text
    Journal Article
  16. 16

    Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review by Lominadze, Zurabi, Hill, Kareen, Shaik, Mohammed Rifat, Canakis, Justin P, Bourmaf, Mohammad, Adams-Mardi, Cyrus, Abutaleb, Ameer, Mishra, Lopa, Shetty, Kirti

    “…The emerging field of immuno-oncology has brought exciting developments in the treatment of hepatocellular carcinoma (HCC). It has also raised urgent questions…”
    Get full text
    Journal Article
  17. 17

    Optogenetic stimulation of the brainstem dorsal motor nucleus ameliorates acute pancreatitis by Thompson, Dane A, Tsaava, Tea, Rishi, Arvind, Nadella, Sandeep, Mishra, Lopa, Tuveson, David A, Pavlov, Valentin A, Brines, Michael, Tracey, Kevin J, Chavan, Sangeeta S

    Published in Frontiers in immunology (25-04-2023)
    “…Inflammation is an inherently self-amplifying process, resulting in progressive tissue damage when unresolved. A brake on this positive feedback system is…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis by Zhou, Xin, PhD, Patel, Darshan, BS, Sen, Sabyasachi, MD, Shanmugam, Victoria, MD, Sidawy, Anton, MD, MPH, Mishra, Lopa, MD, Nguyen, Bao-Ngoc, MD

    Published in Journal of vascular surgery (01-04-2017)
    “…Objective Chronic nonhealing wounds are a major health problem for patients in the United States and worldwide. Diabetes and ischemia are two major risk…”
    Get full text
    Journal Article
  20. 20

    Identification of microRNAs specifically expressed in hepatitis C virus‐associated hepatocellular carcinoma by Diaz, Giacomo, Melis, Marta, Tice, Ashley, Kleiner, David E., Mishra, Lopa, Zamboni, Fausto, Farci, Patrizia

    Published in International journal of cancer (15-08-2013)
    “…Although several studies have investigated the association of miRNAs with hepatocellular carcinoma (HCC), the data published so far are not concordant. A…”
    Get full text
    Journal Article